Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated

Pei-Hsun Tsai1, Chia-Hsiung Cheng2, Chun-Yu Lin1

  • 1Institute of Biochemical Sciences, National Taiwan University, Taipei, Taiwan, R.O.C.

Anticancer Research
|December 7, 2016
PubMed

Insights

Dietary flavonoids luteolin and quercetin reduce prostate cancer cell invasion and stemness. These compounds show potential as anti-metastasis and anti-angiogenesis agents by targeting cancer stem cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Prostate cancer cell invasiveness is a critical factor in metastasis.
  • Cancer stem cells (CSCs) contribute to tumor recurrence and therapeutic resistance.
  • Matrix metalloproteinase 9 (MMP9) plays a role in tumor invasion and vasculogenic mimicry (VM).

Purpose of the Study:

  • To investigate the effects of dietary flavonoids luteolin and quercetin on highly invasive prostate cancer cells.
  • To evaluate the impact of these flavonoids on cancer stem cell properties and invasion.
  • To explore the role of MMP9 and JNK signaling in flavonoid-mediated effects.

Main Methods:

  • Isolation of a highly invasive Du145-III prostate cancer cell subline.
  • Assessment of cell invasion, migration, MMP9 expression, and VM.
  • Analysis of CSC marker expression (Nanog, Sox2, CD44, ABCG2) and self-renewal capacity.
  • Evaluation of luteolin and quercetin effects on these properties, including JNK signaling.

Main Results:

  • Du145-III cells exhibited high invasiveness, MMP9 expression, VM, and CSC characteristics.
  • MMP9 was essential for VM induction and enhanced stemness in Du145-III cells.
  • Luteolin and quercetin significantly reduced the malignancy, VM, spheroid formation, and CSC marker expression in Du145-III cells.
  • Flavonoids modulated JNK signaling pathway activation.

Conclusions:

  • Luteolin and quercetin effectively suppress prostate cancer cell stemness and invasiveness.
  • These flavonoids demonstrate potential as anti-angiogenesis and anti-metastasis agents.
  • Targeting CSCs and inhibiting MMP9-dependent VM are key mechanisms of action.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K